Can Pregabalin Reduce the Frequency and Severity of Dry Eye Symptoms After Laser-assisted in Situ Keratomileusis?

NCT02701764 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2019-11-14

Study results available
· View outcomes & findings →

Summary

Can Lyrica (Pregabalin) help prevent severe Dry Eye post LASIK surgery?

Conditions

  • Dry Eye

Interventions

DRUG

Pregabalin

DRUG

Placebo

Sponsors & Collaborators

  • University of Miami

    lead OTHER

Principal Investigators

  • Anat Galor, MD, MSPH · University of Miami

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-07-26
Primary Completion
2018-12-01
Completion
2018-12-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02701764 on ClinicalTrials.gov